These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 6310865)

  • 1. Fusion resistance and decreased infectability as major host cell determinants of coronavirus persistence.
    Mizzen L; Cheley S; Rao M; Wolf R; Anderson R
    Virology; 1983 Jul; 128(2):407-17. PubMed ID: 6310865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of protease-dependent cell membrane fusion in persistent and lytic infections of murine hepatitis virus.
    Mizzen L; Daya M; Anderson R
    Adv Exp Med Biol; 1987; 218():175-86. PubMed ID: 2829527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early events of importance in determining host cell permissiveness to mouse hepatitis virus infection.
    Kooi C; Mizzen L; Alderson C; Daya M; Anderson R
    J Gen Virol; 1988 Jun; 69 ( Pt 6)():1125-35. PubMed ID: 2838566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholesterol enhances mouse hepatitis virus-mediated cell fusion.
    Daya M; Cervin M; Anderson R
    Virology; 1988 Apr; 163(2):276-83. PubMed ID: 2833007
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutation of host cell determinants which discriminate between lytic and persistent mouse hepatitis virus infection results in a fusion-resistant phenotype.
    Daya M; Wong F; Cervin M; Evans G; Vennema H; Spaan W; Anderson R
    J Gen Virol; 1989 Dec; 70 ( Pt 12)():3335-46. PubMed ID: 2558160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model for persistent murine coronavirus infection involving maintenance via cytopathically infected cell centres.
    Macintyre G; Wong F; Anderson R
    J Gen Virol; 1989 Mar; 70 ( Pt 3)():763-8. PubMed ID: 2543759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse fibroblast mutants selected for survival against mouse hepatitis virus infection show increased resistance to infection and virus-induced cell fusion.
    Daya M; Wong F; Cervin M; Evans G; Vennema H; Spaan WJ; Anderson R
    Adv Exp Med Biol; 1990; 276():59-66. PubMed ID: 1966453
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: host-dependent differences in proteolytic cleavage and cell fusion.
    Frana MF; Behnke JN; Sturman LS; Holmes KV
    J Virol; 1985 Dec; 56(3):912-20. PubMed ID: 2999444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of lytic plaques by murine leukemia virus in murine sarcoma virus-transformed nonproducer mouse cells persistently infected with mouse hepatitis virus MHV-S.
    Yoshikura H; Taguchi F
    Intervirology; 1979; 11(2):69-73. PubMed ID: 218897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Murine coronavirus requires lipid rafts for virus entry and cell-cell fusion but not for virus release.
    Choi KS; Aizaki H; Lai MM
    J Virol; 2005 Aug; 79(15):9862-71. PubMed ID: 16014947
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using a defective-interfering RNA system to express the HE protein of mouse hepatitis virus for studying viral pathogenesis.
    Zhang X; Hinton D; Park S; Liao CL; Lai MM; Stohlman S
    Adv Exp Med Biol; 1998; 440():521-8. PubMed ID: 9782324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.
    Qiu Z; Hingley ST; Simmons G; Yu C; Das Sarma J; Bates P; Weiss SR
    J Virol; 2006 Jun; 80(12):5768-76. PubMed ID: 16731916
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the membrane cytopathology of mouse hepatitis virus infection as probed by a semi-permeable translation-inhibiting drug.
    Macintyre G; Kooi C; Wong F; Anderson R
    Adv Exp Med Biol; 1990; 276():67-72. PubMed ID: 1966463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of peplomer cleavage site mutations arising during persistence of MHV-A59.
    Gombold JL; Hingley ST; Weiss SR
    Adv Exp Med Biol; 1993; 342():157-63. PubMed ID: 8209723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A spike protein-dependent cellular factor other than the viral receptor is required for mouse hepatitis virus entry.
    Yokomori K; Asanaka M; Stohlman SA; Lai MM
    Virology; 1993 Sep; 196(1):45-56. PubMed ID: 8395126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells.
    Stohlman SA; Weiner LP
    Arch Virol; 1978; 57(1):53-61. PubMed ID: 207241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance to infection with mouse hepatitis virus (MHV) in the cell clones derived from persistently infected DBT cells with the JHM strain of MHV.
    Maeda A; Kon Y; Watanabe T; Hayashi M
    J Vet Med Sci; 1997 Jul; 59(7):545-9. PubMed ID: 9271448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polypyrimidine-tract-binding protein affects transcription but not translation of mouse hepatitis virus RNA.
    Choi KS; Huang Py; Lai MM
    Virology; 2002 Nov; 303(1):58-68. PubMed ID: 12482658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion.
    Phillips JM; Gallagher T; Weiss SR
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28148786
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple regions of the murine coronavirus spike glycoprotein influence neurovirulence.
    Phillips JJ; Chua M; Seo SH; Weiss SR
    J Neurovirol; 2001 Oct; 7(5):421-31. PubMed ID: 11582514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.